FDA.reportPublic FDA data

30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler

RxCUI
1424889
RxNorm name
30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
Display name
30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
Full name
30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fluticasone Furoate and VilanterolFLUTICASONE FUROATE AND VILANTEROLPrasco Laboratories3a761487-c300-451a-8537-3196c00c11b52024-11-21Warnings, Adverse reactionsExact identifier
rxcui: 1424889
Breo ElliptaFLUTICASONE FUROATE AND VILANTEROL TRIFENATATEGlaxoSmithKline LLC96428df1-ea05-431a-98d3-1ec2c4b638782024-11-07Warnings, Adverse reactionsExact identifier
rxcui: 1424889

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
96428df1-ea05-431a-98d3-1ec2c4b63878fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters [PSN] · 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [SCD]228These highlights do not include all the information needed to use BREO ELLIPTA safely and effectively. See full prescribing information for BREO ELLIPTA. BREO ELLIPTA (fluticasone furoate and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 201320241107
3a761487-c300-451a-8537-3196c00c11b5fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters [PSN] · 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [SCD]26These highlights do not include all the information needed to use Fluticasone Furoate/Vilanterol ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate/Vilanterol ELLIPTA. Fluticasone Furoate/Vilanterol ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 201320241121